Updated risk-oriented strategy for acute lymphoblastic leukemia in adult patients 18–65 years: NILG ALL 10/07Renato Bassan, Alessandro Rambaldi, Agostino Cortelezzi et al.|Blood Cancer Journal|2020Cited by 45
Randomized trial of radiation-free central nervous system prophylaxis comparing intrathecal triple therapy with liposomal cytarabine in acute lymphoblastic leukemiaRenato Bassan, Alessandro Rambaldi, Arianna Masciulli et al.|Haematologica|2015Cited by 32
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)Renato Bassan, Alessandro Rambaldi, Arianna Masciulli et al.|Blood|2016Cited by 22
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocolRenato Bassan, Robin Foà, Monica Fumagalli et al.|Leukemia & lymphoma/Leukemia and lymphoma|2019Cited by 7
Phase II Randomized Trial Of Radiation-Free Central Nervous System (CNS) Prophylaxis Comparing Intrathecal Triple Therapy With Liposomal Cytarabine (DepoCyte®) In Adult Acute Lymphoblastic Leukemia (ALL)Renato Bassan, Alessandro Rambaldi, Arianna Masciulli et al.|Blood|2013Cited by 2